BIOSTAR PHARM-B(02563): Zhu Pai resigns as non-executive director
Hua Hao Zhongtian Medicine-B (02563) announced that Mr. Zhu Pai has submitted his resignation as he intends to devote more time to deal with other matters.
BIOSTAR PHARM-B (02563) announced that Mr. Zhu Pai has resigned as a non-executive director, effective from May 23, 2025, as he intends to devote more time to other matters.
Related Articles
US Stock Market Move | Negotiations between Nippon Steel and the U.S. government have entered the "final stage". United States Steel Corporation (X.US) has risen more than 7%.
US Stock Market Move | Large-cap tech stocks fell, with NVIDIA Corporation (NVDA.US) dropping more than 1.3%.
US Stock Market Move | Financial performance forecast for the 2026 fiscal year falls short of expectations, causing a sharp drop of over 14% in shares of Booz Allen Hamilton (BAH.US).
US Stock Market Move | Negotiations between Nippon Steel and the U.S. government have entered the "final stage". United States Steel Corporation (X.US) has risen more than 7%.
US Stock Market Move | Large-cap tech stocks fell, with NVIDIA Corporation (NVDA.US) dropping more than 1.3%.
US Stock Market Move | Financial performance forecast for the 2026 fiscal year falls short of expectations, causing a sharp drop of over 14% in shares of Booz Allen Hamilton (BAH.US).
RECOMMEND
Xiaomi Unveils 3nm Chip and YU7 SUV at 15th Anniversary Event
23/05/2025
BYD Surpasses Tesla in European EV Sales for the First Time in April with 169% Surge; Tesla Sees 45% Q1 Decline, Musk Reaffirms CEO Role for Five More Years
23/05/2025
U.S. FTC Officially Withdraws Case Against Microsoft’s $69 Billion Acquisition of Activision Blizzard
23/05/2025
